Home > Journals > International Angiology > Past Issues > International Angiology 1998 June;17(2) > International Angiology 1998 June;17(2):65-8





A Journal on Angiology

Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,37




International Angiology 1998 June;17(2):65-8


language: English

Staged basilic vein transposition for dialisys angioaccess

El Mallah S.

From the Surgery Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt


Background. To find out a suit­able pro­ce­dure to dis­sect an arte­ri­al­ised thick ­walled vein to ­create sec­on­dary angioac­cess for dial­y­sis. Delicacy of the vein wall, high rate of throm­bo­sis and dif­fi­cul­ty to find out a suit­able vein are the main obsta­cles to vas­cu­lar sur­geons dur­ing the crea­tion of sec­on­dary angioac­cess.
Methods. Forty ­patients in need for sec­on­dary angioac­cess for dial­y­sis were admit­ted for basil­ic vein trans­po­si­tion. They were clas­si­fied ran­dom­ly into two equal ­groups ­matched for age and sex. Group A ­patients were sub­mit­ted to tra­di­tion­al basil­ic vein trans­po­si­tion. In group B, the oper­a­tion was done in two stag­es. In the first stage, brach­i­ob­a­sil­ic anas­tom­o­sis was done. Two to four weeks later the sec­ond stage was done to 19 ­patients (one ­patient had occlud­ed shunt ­before the sec­ond stage) in the form of super­fi­cial­iza­tion of the vein to be ­placed in the sub­cu­ta­ne­ous tis­sue.
Results. Follow-up peri­od for 6-24 ­months ­revealed that in the early post­op­er­a­tive peri­od (4 weeks after oper­a­tion) paten­cy rate was 12/20 (60%) in group A and 18/20 (90%) with sig­nif­i­cant dif­fer­ence (p<0.05) ­between the two ­groups. Later, occlu­sion ­occurred in two ­patients in each group. At the end of the study the over­all paten­cy was 10/20 (50%) and 16/20 (80%) in group A and B respec­tive­ly with sig­nif­i­cant dif­fer­ence ­between them. Both ­groups were sim­i­lar in minor com­pli­ca­tions.
Conclusions. The ­staged basil­ic vein trans­po­si­tion is super­i­or to the tra­di­tion­al oper­a­tion in the paten­cy rate and is rec­om­mend­ed as a safe oper­a­tion for a suc­cess­ful sec­on­dary angioac­cess.

top of page

Publication History

Cite this article as

Corresponding author e-mail